Study of Changes in Carbohydrate Metabolism in Patients with Sars-Cov-2

Abstract

Covid-19 infection, one of the most urgent problems of the 21st century, was first detected in December 2019 in Wuhan, China, and was declared a pandemic by the World Health Organization on March 11, 2020. According to the WHO, the elderly patients with concomitant diseases dominate the structure of infection with the new coronavirus. Cardiovascular system diseases, diabetes mellitus (DM), obesity, and chronic diseases are the most common among concomitant diseases. It is known that the main target organs of the SARS-CoV2 are the mucous membranes of the respiratory tract and the gastrointestinal tract. However, the virus uses ACE2 receptors to enter the cell, and this receptor is present not only in the lungs, but also in many other tissues and organs, including the exocrine part of the pancreas and the islets of Langerhans.